These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6237151)

  • 1. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function.
    Frey BM; Walker C; Frey FJ; de Weck AL
    J Immunol; 1984 Nov; 133(5):2479-87. PubMed ID: 6237151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of 3 prednisolone prodrugs. Evidence of therapeutic inequivalence in renal transplant patients with rejection.
    Frey BM; Seeberger M; Frey FJ
    Transplantation; 1985 Mar; 39(3):270-4. PubMed ID: 3883592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration-dependent effects of prednisolone on lymphocyte subsets and mixed lymphocyte culture in humans.
    Oosterhuis B; ten Berge IJ; Schellekens PT; van Boxtel CJ
    J Pharmacol Exp Ther; 1987 Nov; 243(2):716-22. PubMed ID: 2960797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of altered prednisolone kinetics in patients with the nephrotic syndrome and in women taking oral contraceptive steroids on human mixed lymphocyte cultures.
    Frey BM; Frey FJ
    J Clin Endocrinol Metab; 1985 Feb; 60(2):361-9. PubMed ID: 3155524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit.
    Unadkat JD; Rowland M
    Drug Metab Dispos; 1985; 13(4):503-9. PubMed ID: 2863117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednisolone pharmacodynamics assessed by inhibition of the mixed lymphocyte reaction.
    Frey BM; Frey FJ; Holford NH; Lozada F; Benet LZ
    Transplantation; 1982 Jun; 33(6):578-84. PubMed ID: 6213074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of prednisolone after intravenous and oral administration.
    Barth J; Damoiseaux M; Möllmann H; Brandis KH; Hochhaus G; Derendorf H
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):317-24. PubMed ID: 1428295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of sucralfate on prednisone bioavailability.
    Gambertoglio JG; Romac DR; Yong CL; Birnbaum J; Lizak P; Amend WJ
    Am J Gastroenterol; 1987 Jan; 82(1):42-5. PubMed ID: 3799579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisone-induced alterations of circulating human lymphocyte subsets.
    Slade JD; Hepburn B
    J Lab Clin Med; 1983 Mar; 101(3):479-87. PubMed ID: 6219171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic parameters of prednisone and prednisolone in healthy volunteers].
    Etienne SD; Vandermeersch V; Chosidow O; Vu-Thi-My-Le C; Godeau P; Diquet B; Herson S
    Ann Med Interne (Paris); 1990; 141(6):507-11. PubMed ID: 2285202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive activity of prednisone and prednisolone and their metabolic interconversion in the mixed lymphocyte reaction.
    Tsang SY; Garovoy MR; Benet LZ
    Int J Immunopharmacol; 1985; 7(5):731-7. PubMed ID: 2931388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
    Frey BM; Sieber M; Mettler D; Gänger H; Frey FJ
    Drug Metab Dispos; 1988; 16(2):285-9. PubMed ID: 2898348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenytoin modulates the pharmacokinetics of prednisolone and the pharmacodynamics of prednisolone as assessed by the inhibition of the mixed lymphocyte reaction in humans.
    Frey BM; Frey FJ
    Eur J Clin Invest; 1984 Feb; 14(1):1-6. PubMed ID: 6230241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary 6 beta-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism.
    Frey FJ; Frey BM
    J Lab Clin Med; 1983 Apr; 101(4):593-604. PubMed ID: 6833830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive effects of low doses of glucocorticoids: effects on autologous and allogeneic mixed leukocyte reactions.
    Hahn BH; MacDermott RP; Jacobs SB; Pletscher LS; Beale MG
    J Immunol; 1980 Jun; 124(6):2812-7. PubMed ID: 6445384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible metabolism and pharmacokinetics: application to prednisone-prednisolone.
    Wagner JG; DiSanto AR; Gillespie WR; Albert KS
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):387-405. PubMed ID: 7268190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics.
    Gummert JF; Barten MJ; Sherwood SW; van Gelder T; Morris RE
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1100-12. PubMed ID: 10565830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function.
    Fauci AS
    Clin Exp Immunol; 1976 Apr; 24(1):54-62. PubMed ID: 1084818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution of prednisolone in the rabbit.
    Khalafallah N; Jusko WJ
    J Pharmacol Exp Ther; 1984 Jun; 229(3):719-25. PubMed ID: 6726655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.